JPH0720937B2 - Process for producing 2-aryl-5-halogenopyridine derivative - Google Patents
Process for producing 2-aryl-5-halogenopyridine derivativeInfo
- Publication number
- JPH0720937B2 JPH0720937B2 JP2052521A JP5252190A JPH0720937B2 JP H0720937 B2 JPH0720937 B2 JP H0720937B2 JP 2052521 A JP2052521 A JP 2052521A JP 5252190 A JP5252190 A JP 5252190A JP H0720937 B2 JPH0720937 B2 JP H0720937B2
- Authority
- JP
- Japan
- Prior art keywords
- atom
- group
- compound
- atoms
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title description 10
- 150000001875 compounds Chemical class 0.000 claims description 56
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 28
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 14
- 229910052763 palladium Inorganic materials 0.000 claims description 14
- 239000003054 catalyst Substances 0.000 claims description 12
- 229910052801 chlorine Inorganic materials 0.000 claims description 12
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- 229910052740 iodine Inorganic materials 0.000 claims description 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
- 125000004434 sulfur atom Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 4
- 125000005662 2,5-pyridylene group Chemical group [H]C1=NC([*:1])=C([H])C([H])=C1[*:2] 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- -1 n-octyl group Chemical group 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- ZHXUWDPHUQHFOV-UHFFFAOYSA-N 2,5-dibromopyridine Chemical compound BrC1=CC=C(Br)N=C1 ZHXUWDPHUQHFOV-UHFFFAOYSA-N 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- TXOYFEVZPWFUDM-UHFFFAOYSA-N (2,3-dichloro-3-diphenylphosphanylbutan-2-yl)-diphenylphosphane Chemical compound ClC(C(C)(P(C1=CC=CC=C1)C1=CC=CC=C1)Cl)(C)P(C1=CC=CC=C1)C1=CC=CC=C1 TXOYFEVZPWFUDM-UHFFFAOYSA-N 0.000 description 4
- 239000007818 Grignard reagent Substances 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000004795 grignard reagents Chemical class 0.000 description 4
- 239000004973 liquid crystal related substance Substances 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 3
- FDOQGGGFQVVOBN-UHFFFAOYSA-N 2-fluoro-4-iodophenol Chemical compound OC1=CC=C(I)C=C1F FDOQGGGFQVVOBN-UHFFFAOYSA-N 0.000 description 3
- 101150065749 Churc1 gene Proteins 0.000 description 3
- 102100038239 Protein Churchill Human genes 0.000 description 3
- 239000004990 Smectic liquid crystal Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000006880 cross-coupling reaction Methods 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 150000003018 phosphorus compounds Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 2
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 description 2
- MNDIARAMWBIKFW-UHFFFAOYSA-N 1-bromohexane Chemical compound CCCCCCBr MNDIARAMWBIKFW-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 229940058905 antimony compound for treatment of leishmaniasis and trypanosomiasis Drugs 0.000 description 2
- 150000001463 antimony compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- SRMCCEAXOINPMD-ZPUQHVIOSA-N (1e,4e)-1,5-dichloropenta-1,4-dien-3-one Chemical compound Cl\C=C\C(=O)\C=C\Cl SRMCCEAXOINPMD-ZPUQHVIOSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LSXKDWGTSHCFPP-UHFFFAOYSA-N 1-bromoheptane Chemical compound CCCCCCCBr LSXKDWGTSHCFPP-UHFFFAOYSA-N 0.000 description 1
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 1
- OVFOTTIEEHWKEL-UHFFFAOYSA-N 1-hexoxy-2-iodobenzene Chemical compound CCCCCCOC1=CC=CC=C1I OVFOTTIEEHWKEL-UHFFFAOYSA-N 0.000 description 1
- LGBIFIGDFFVXIW-UHFFFAOYSA-N 1-hexoxy-4-iodobenzene Chemical compound CCCCCCOC1=CC=C(I)C=C1 LGBIFIGDFFVXIW-UHFFFAOYSA-N 0.000 description 1
- GCTFDMFLLBCLPF-UHFFFAOYSA-N 2,5-dichloropyridine Chemical compound ClC1=CC=C(Cl)N=C1 GCTFDMFLLBCLPF-UHFFFAOYSA-N 0.000 description 1
- QUTKAHHXACSXSU-UHFFFAOYSA-N 2-fluoro-1-heptoxy-4-iodobenzene Chemical compound CCCCCCCOC1=CC=C(I)C=C1F QUTKAHHXACSXSU-UHFFFAOYSA-N 0.000 description 1
- SGKLCZAEKHOYLF-UHFFFAOYSA-N 2-fluoro-4-iodo-1-octoxybenzene Chemical compound CCCCCCCCOC1=CC=C(I)C=C1F SGKLCZAEKHOYLF-UHFFFAOYSA-N 0.000 description 1
- VSMDINRNYYEDRN-UHFFFAOYSA-N 4-iodophenol Chemical compound OC1=CC=C(I)C=C1 VSMDINRNYYEDRN-UHFFFAOYSA-N 0.000 description 1
- 101100135744 Caenorhabditis elegans pch-2 gene Proteins 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical group [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical group [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 150000001495 arsenic compounds Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229940093920 gynecological arsenic compound Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は2−アリール−5−ハロゲノピリジン誘導体の
製法に関する。TECHNICAL FIELD The present invention relates to a method for producing a 2-aryl-5-halogenopyridine derivative.
[従来の技術] 従来2−アリール−5−ハロゲノピリジン誘導体の製造
法としては、アリールリチウム誘導体とピリジンとの反
応を経由し、 を製造する方法(例えば特開昭63-174973号公報)など
が知られている。[Prior Art] Conventionally, as a method for producing a 2-aryl-5-halogenopyridine derivative, a reaction between an aryllithium derivative and pyridine is carried out, There is known a method for producing (see, for example, JP-A-63-174973).
[発明が解決しようとする課題] しかし上記の製造法は、合成ルートが長いうえに、収率
も高くないなどの問題があった。[Problems to be Solved by the Invention] However, the above-mentioned production method has problems that the synthesis route is long and the yield is not high.
[課題を解決するための手段] 本発明者らは上記の様な問題点を解決し、従来の方法に
比べ短い合成ルートで、高収率に2−アリール−5−ハ
ロゲノピリジン誘導体を得ることを目的に鋭意検討を行
った結果、本発明に到達した。[Means for Solving the Problems] The present inventors have solved the above problems and obtained a 2-aryl-5-halogenopyridine derivative in high yield with a shorter synthetic route than conventional methods. As a result of intensive studies aimed at, the present invention has been achieved.
すなわち本発明は、一般式 〔式中、Xは塩素原子、臭素原子またはヨウ素原子を、 は2,5−ピリジレン基を表す〕で示される2,5−ジハロゲ
ノピリジンと一般式 R-Y-A-Mg-X1 (2) 〔式中、Rは炭素数1〜18のアルキル基(該アルキル基
は、1個または2個のCH2がO原子、S原子および−CH
=CH−からなる群より選ばれるものにより、2個のO原
子またはS原子が相互に直接に結合していないものとし
て置き換えられていてもよい)、X1は塩素原子、臭素原
子またはヨウ素原子、Aは芳香環の水素原子の一部また
は全部がフッ素原子または塩素原子で置換されていても
よい1,4−フェニレン基または4,4′−ビフェニレン基、
Yは−O−、−S−、−C≡C−または直接結合を表
す〕で示される化合物とを、0価または2価のパラジウ
ム触媒もしくは0価または2価のニッケル触媒存在下に
クロスカップリングさせることを特徴とする一般式 〔式中、Rは炭素数1〜18のアルキル基(該アルキル基
は、1個または2個のCH2がO原子、S原子および−CH
=CH−からなる群より選ばれるものにより、2個のO原
子またはS原子が相互に直接に結合していないものとし
て置き換えられていてもよい)、 は2,5−ピリジレン基、Xは塩素原子、臭素原子または
ヨウ素原子、Aは芳香環の水素原子の一部または全部が
フッ素原子または塩素原子で置換されていてもよい1,4
−フェニレン基または4,4′−ビフェニレン基、Yは−
O−、−S−、−C≡C−または直接結合を表す〕で示
される2−アリール−5−ハロゲノピリジン誘導体の製
造法である。That is, the present invention has the general formula [In the formula, X represents a chlorine atom, a bromine atom or an iodine atom, Represents a 2,5-pyridylene group] and a general formula RYA-Mg-X 1 (2) [wherein, R represents an alkyl group having 1 to 18 carbon atoms (the alkyl group). 1 or 2 CH 2 is an O atom, an S atom or -CH
2 O atoms or S atoms may be replaced by those not directly bonded to each other by a group selected from the group consisting of = CH-), X 1 is a chlorine atom, a bromine atom or an iodine atom. , A is a 1,4-phenylene group or 4,4′-biphenylene group in which some or all of the hydrogen atoms of the aromatic ring may be substituted with fluorine atoms or chlorine atoms,
Y represents -O-, -S-, -C≡C- or a direct bond] with a compound represented by a formula (I) in the presence of a zero-valent or divalent palladium catalyst or a zero-valent or divalent nickel catalyst. General formula characterized by ringing [In the formula, R is an alkyl group having 1 to 18 carbon atoms (in the alkyl group, 1 or 2 CH 2 is an O atom, an S atom, and -CH
Two O atoms or S atoms may be replaced by those selected from the group consisting of = CH- as not directly bonded to each other), Is a 2,5-pyridylene group, X is a chlorine atom, a bromine atom or an iodine atom, and A is a hydrogen atom of an aromatic ring, part or all of which may be substituted with a fluorine atom or a chlorine atom.
-Phenylene group or 4,4'-biphenylene group, Y is-
O-, -S-, -C [identical to] C- or a direct bond] is a process for producing a 2-aryl-5-halogenopyridine derivative.
一般式(1)で示される化合物は特には限定されない
が、好ましいものとしては、2,5−ジブロモピリジン、
2,5−ジクロロピリジン等が挙げられる。The compound represented by the general formula (1) is not particularly limited, but preferred are 2,5-dibromopyridine,
2,5-dichloropyridine and the like can be mentioned.
一般式(2)、(3)において、Rを示す炭素数1〜18
のアルキル基としては、エチル基、n−プロピル基、n
−ブチル基、n−ペンチル基、n−ヘキシル基、n−ヘ
プチル基、n−オクチル基、n−ノニル基、n−デシル
基、n−ウンデシル基、n−ドデシル基、n−テトラデ
シル基、n−ヘキサデシル基およびn−オクタデシル基
等があげられる。In the general formulas (2) and (3), the number of carbon atoms showing R is 1 to 18
Examples of the alkyl group include ethyl group, n-propyl group, n
-Butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, n-nonyl group, n-decyl group, n-undecyl group, n-dodecyl group, n-tetradecyl group, n -Hexadecyl group, n-octadecyl group and the like.
これらのうち、好ましいものは炭素数2〜14のアルキル
基である。Of these, preferred is an alkyl group having 2 to 14 carbon atoms.
Aを示す芳香環の水素原子の一部または全部がフッ素原
子または塩素原子で置換されていてもよい1,4−フェニ
レン基または4,4′−ビフェニレン基のうち好ましいも
のは、芳香環の1個の水素原子がフッ素原子で置換され
ていてもよい1,4−フェニレン基または4,4′−ビフェニ
レン基である。Among the 1,4-phenylene group or 4,4'-biphenylene group in which some or all of the hydrogen atoms of the aromatic ring represented by A may be substituted with a fluorine atom or a chlorine atom, preferred is 1 of the aromatic ring. Hydrogen atom is a 1,4-phenylene group or 4,4'-biphenylene group optionally substituted with fluorine atoms.
一般式(2)で示される化合物の具体例としては、表−
1に示すような基を有する化合物が挙げられる。Specific examples of the compound represented by the general formula (2) are shown in Table-
Examples thereof include compounds having a group as shown in 1.
一般式(3)で示される化合物の具体例としては、表−
2に示すような基を有する化合物が挙げられる。 Specific examples of the compound represented by the general formula (3) are shown in Table-
Examples thereof include compounds having a group as shown in 2.
表−1、表−2中、各記号はそれぞれ以下の基を表す。 In Table-1 and Table-2, each symbol represents the following groups.
BUT;n-C4H9‐ HEX;n-C6H13‐ OCT;n-C8H17‐ 一般式(2)に含まれる化合物は、例えば次の工程を経
て合成できる(下記式中、X1、Y、AおよびRは一般式
(2)の場合と同一である)。BUT; nC 4 H 9 -HEX; nC 6 H 13 -OCT; nC 8 H 17 -The compound contained in the general formula (2) can be synthesized, for example, through the following steps (wherein X 1 , Y, A and R are the same as in the case of the general formula (2)).
Yが直接結合の場合。 When Y is a direct bond.
すなわち、一般式(4)の化合物に金属マグネシウムを
作用させることにより、一般式(2a)の化合物を得るこ
とができる。 That is, the compound of the general formula (2a) can be obtained by reacting the compound of the general formula (4) with magnesium metal.
Yが−O−または−S−の場合。 When Y is -O- or -S-.
すなわち、一般式(5)の化合物を塩基(例えば水酸化
ナトリウム)の存在下、一般式(6)のアルキル化剤
(例えばハロゲン化アルキル)と反応させて一般式
(7)の化合物を得る。 That is, the compound of general formula (5) is reacted with an alkylating agent of general formula (6) (for example, an alkyl halide) in the presence of a base (for example, sodium hydroxide) to obtain a compound of general formula (7).
一般式(7)の化合物に金属マグネシウムを作用させる
ことにより一般式(2b)の化合物を得ることができる。The compound of general formula (2b) can be obtained by reacting the compound of general formula (7) with magnesium metal.
Yが−C≡C−の場合。 When Y is -C≡C-.
すなわち、一般式(8)の化合物と一般式(9)の化合
物を、トリエチルアミン中不活性ガス雰囲気下、0価ま
たは2価のパラジウム触媒およびヨウ化銅を用いて反応
させることにより、一般式(10)の化合物を得る。 That is, by reacting the compound of the general formula (8) with the compound of the general formula (9) in triethylamine under an inert gas atmosphere using a zero-valent or divalent palladium catalyst and copper iodide, The compound of 10) is obtained.
一般式(10)の化合物に金属マグネシウムを作用させる
ことにより一般式(2c)の化合物を得ることができる。The compound of general formula (2c) can be obtained by reacting the compound of general formula (10) with magnesium metal.
一般式(1)の化合物と一般式(2)の化合物とを0価
または2価のパラジウム触媒もしくは0価または2価の
ニッケル触媒存在下にクロスカップリングさせることに
より、一般式(3)の化合物である2−アリール−5−
ハロゲノピリジン誘導体が得られる。By cross-coupling the compound of general formula (1) and the compound of general formula (2) in the presence of a zero-valent or divalent palladium catalyst or a zero-valent or divalent nickel catalyst, The compound 2-aryl-5
A halogenopyridine derivative is obtained.
本発明において、クロスカップリング反応は通常溶媒の
存在下で行う。この反応に用いられる溶媒としては、ジ
エチルエーテル、テトラヒドロフラン、ジオキサン、グ
ライム、ジグライムなどの非プロトン性溶媒が挙げられ
る。これらのうち、好ましいものはジエチルエーテルお
よびテトラヒドロフランである。In the present invention, the cross coupling reaction is usually performed in the presence of a solvent. Examples of the solvent used in this reaction include aprotic solvents such as diethyl ether, tetrahydrofuran, dioxane, glyme and diglyme. Of these, preferred are diethyl ether and tetrahydrofuran.
溶媒の使用量は一般式(2)の化合物の2〜100重量
倍、好ましくは3〜20重量倍が適している。The amount of the solvent used is 2 to 100 times by weight, preferably 3 to 20 times by weight that of the compound of the general formula (2).
本クロスカップリング反応に用いられる0価または2価
のパラジウム触媒もしくは0価または2価のニッケル触
媒は次の一般式で表すことができる。The zero-valent or divalent palladium catalyst or the zero-valent or divalent nickel catalyst used in this cross-coupling reaction can be represented by the following general formula.
L2M(2)Q2,L2M(2)Q2,L4M(0)orM(2)Q2 (11) 〔式中、M(2)は2価のパラジウムあるいは2価のニ
ッケルを、M(0)は0価のパラジウムあるいは0価の
ニッケルを表す。Lは1分子中に1個のZ′(リン原
子、ヒ素原子またはアンチモン原子)を有する配位子を
表し、L2は1分子中に2個のZ′を有する配位子を表
す。Qは塩素原子、臭素原子、ヨウ素原子、-OOCCH
3基、-OOCC2H5基、-OOCC3H7基、-OOCC4H9基または -OC(CH3=CHCOCH3基を表す。反応系中でL2M(2)Q2あるい
はL2M(2)Q2がわずかでも形成されれば、LとM(2)Q2ある
いはL2とM(2)Q2を別個にかつ任意の割合で添加でき、こ
の場合の触媒系(L+M(2)Q2あるいはL2+M(2)Q2)もL2
M(2)Q2あるいはL2M(2)Q2と同等の意義を有する。〕 上記一般式で表されるパラジウム触媒あるいはニッケル
触媒において、Mのうち好ましいものはパラジウムであ
る。L 2 M (2) Q 2 , L 2 M (2) Q 2 , L 4 M (0) orM (2) Q 2 (11) [wherein M (2) is divalent palladium or divalent Nickel and M (0) represents zero-valent palladium or zero-valent nickel. L represents a ligand having one Z '(phosphorus atom, arsenic atom or antimony atom) in one molecule, and L 2 represents a ligand having two Z'in one molecule. Q is chlorine atom, bromine atom, iodine atom, -OOCCH
3 groups, -OOCC 2 H 5 group, -OOCC 3 H 7 group, -OOCC 4 H 9 group or -OC (CH 3 = CHCOCH 3 group. In the reaction system, L 2 M (2) Q 2 or L If even a small amount of 2 M (2) Q 2 is formed, L and M (2) Q 2 or L 2 and M (2) Q 2 can be added separately and at an arbitrary ratio. L + M (2) Q 2 or L 2 + M (2) Q 2 ) is also L 2
It has the same meaning as M (2) Q 2 or L 2 M (2) Q 2 . In the palladium catalyst or nickel catalyst represented by the above general formula, palladium is preferable among M.
配位子Lとしては、例えば (CH3)3P、(C2H5)3P、 (CH2=CHCH2)3P、 (C3H7)3P、(C4H9)3P、(C5H11)3P、 (C6H13)3P、(C7H15)3P、 (C8H17)3P、(C6H11)3P、(C6H5)3P、 (CH3C6H4)3P、(ClC6H4)3P、 (CH3OC6H4)3P、(C6H5CH2)3P、 (C4H9)2(C6H5)P、 (C4H9)(C6H5)2P、 (CH3OC6H4)(C6H5)2P、 (CH3O)3P、(C2H5O)3P、 (C5H11O)3P、(C8H17O)3P、 (C6H5CH2O)3P、(C6H5O)3P、 (CH3C6H4O)3P、(ClC6H4O)3P、 (CH3OC6H4O)3P、 (CH3O)(C6H5)2P、 (C4H9O)2(C6H5)P、 (CH3C6H4O)(C6H5)2P、 (C4H9O)(C6H5O)2Pなどのリン化合物、 (CH3)3As、(C2H5)3As、 (CH2=CHCH2)3As、(C3H7)3As、 (C4H9)3As、(C6H13)3As、 (C8H17)3As、(C6H5CH2)3As、 (C6H5)3As、(CH3C6H4)3As、 (CH3OC6H4)3As、(ClC6H4)3As、 などのヒ素化合物、 (CH3)3Sb、(C2H5)3Sb、 (CH2=CHCH2)3Sb、(C3H7)3Sb、 (C4H9)3Sb、(C6H13)3Sb、 (C8H17)3Sb、(C6H5CH2)3Sb、 (C6H5)3Sb、(CH3C6H4)3Sb、 (CH3OC6H4)3Sb、(ClC6H4)3Sb、 などのアンチモン化合物等が挙げられる。Examples of the ligand L include (CH 3 ) 3 P, (C 2 H 5 ) 3 P, (CH 2 = CHCH 2 ) 3 P, (C 3 H 7 ) 3 P, (C 4 H 9 ) 3 P, (C 5 H 11 ) 3 P, (C 6 H 13 ) 3 P, (C 7 H 15 ) 3 P, (C 8 H 17 ) 3 P, (C 6 H 11 ) 3 P, (C 6 H 5) 3 P, (CH 3 C 6 H 4) 3 P, (ClC 6 H 4) 3 P, (CH 3 OC 6 H 4) 3 P, (C 6 H 5 CH 2) 3 P, (C 4 H 9 ) 2 (C 6 H 5 ) P, (C 4 H 9 ) (C 6 H 5 ) 2 P, (CH 3 OC 6 H 4 ) (C 6 H 5 ) 2 P, (CH 3 O) 3 P, (C 2 H 5 O) 3 P, (C 5 H 11 O) 3 P, (C 8 H 17 O) 3 P, (C 6 H 5 CH 2 O) 3 P, (C 6 H 5 O) 3 P, (CH 3 C 6 H 4 O) 3 P, (ClC 6 H 4 O) 3 P, (CH 3 OC 6 H 4 O) 3 P, (CH 3 O) (C 6 H 5 ) 2 P, (C 4 H 9 O) 2 (C 6 H 5 ) P, (CH 3 C 6 H 4 O) (C 6 H 5 ) 2 P, (C 4 H 9 O) (C 6 H 5 O ) 2 P and other phosphorus compounds, (CH 3 ) 3 As, (C 2 H 5 ) 3 As, (CH 2 = CHCH 2 ) 3 As, (C 3 H 7 ) 3 As, (C 4 H 9 ) 3 As, (C 6 H 13) 3 As, (C 8 H 17) 3 As, (C 6 H 5 CH 2) 3 As, (C 6 H 5) 3 As, (CH 3 C 6 H 4) 3 As , (CH 3 OC 6 H 4 ) 3 As, (ClC 6 H 4) 3 As, such as Containing compound, (CH 3) 3 Sb, (C 2 H 5) 3 Sb, (CH 2 = CHCH 2) 3 Sb, (C 3 H 7) 3 Sb, (C 4 H 9) 3 Sb, (C 6 H 13 ) 3 Sb, (C 8 H 17 ) 3 Sb, (C 6 H 5 CH 2 ) 3 Sb, (C 6 H 5 ) 3 Sb, (CH 3 C 6 H 4 ) 3 Sb, (CH 3 OC Examples thereof include antimony compounds such as 6 H 4 ) 3 Sb and (ClC 6 H 4 ) 3 Sb.
配位子L2としては、例えば (C6H5)2PCH2CH2P(C6H5)2、 (C6H5)2PCH2CH2CH2P(C6H5)2、 などのリン化合物、 などのヒ素化合物、 などのアンチモン化合物等が挙げられる。The ligand L 2, for example (C 6 H 5) 2 PCH 2 CH 2 P (C 6 H 5) 2, (C 6 H 5) 2 PCH 2 CH 2 CH 2 P (C 6 H 5) 2 , Phosphorus compounds, such as Arsenic compounds, such as And antimony compounds.
これらの配位子LまたはL2のうち、好ましいものはリン
化合物であり、特に好ましいものは (C6H5)3P、 (C6H5)2PCH2CH2P(C6H5)2、 (C6H5)2PCH2CH2CH2P(C6H5)2、および である。Of these ligands L or L 2 , preferred are phosphorus compounds, and particularly preferred are (C 6 H 5 ) 3 P and (C 6 H 5 ) 2 PCH 2 CH 2 P (C 6 H 5 ) 2 , (C 6 H 5 ) 2 PCH 2 CH 2 CH 2 P (C 6 H 5 ) 2 , and Is.
Qのうち好ましいものは塩素原子、臭素原子、ヨウ素原
子、-OOCCH3基、-OOCC2H5基および-OOCC3H7基であり、
特に好ましいものは塩素原子、臭素原子、-OOCCH3基お
よび-OOCC2H5基である。Preferred among Q are chlorine atom, bromine atom, iodine atom, -OOCCH 3 group, -OOCC 2 H 5 group and -OOCC 3 H 7 group,
Particularly preferred are chlorine atom, bromine atom, -OOCCH 3 group and -OOCC 2 H 5 group.
パラジウム触媒またはニッケル触媒の使用量は一般式
(2)の化合物に対して通常は0.1〜20モル%でよく、
特に0.1〜5%が好ましいが、これに限定されるもので
はない。The amount of the palladium catalyst or nickel catalyst used may be usually 0.1 to 20 mol% with respect to the compound of the general formula (2),
It is particularly preferably 0.1 to 5%, but not limited to this.
一般式(1)の化合物と一般式(2)の化合物のモル比
は通常10:1〜1:10、好ましくは10:7〜10:15である。The molar ratio of the compound of the general formula (1) to the compound of the general formula (2) is usually 10: 1 to 1:10, preferably 10: 7 to 10:15.
本カップリング反応の反応温度は通常−20〜100℃、好
ましくは−10〜40℃であり、あまり高温になると触媒が
失活するため好ましくない。The reaction temperature of this coupling reaction is usually −20 to 100 ° C., preferably −10 to 40 ° C., and if the temperature is too high, the catalyst is deactivated, which is not preferable.
本カップリング反応の反応時間は特に制限されず、原料
の2,5−ジハロゲノピリジンが消失した時点を反応の終
点とすることができる。なお、反応の終点はガスクロマ
トグラフィー等を用いて確認することができる。The reaction time of this coupling reaction is not particularly limited, and the time point when the starting material, 2,5-dihalogenopyridine, disappears can be the end point of the reaction. The end point of the reaction can be confirmed using gas chromatography or the like.
反応終了後、通常の分離手段、例えば抽出、洗浄、濃縮
等により反応混合物から目的とする一般式(3)に示さ
れる2−アリール−5−ハロゲノピリジン誘導体を単離
することができ、必要により再結晶、カラムクロマトグ
ラフィー等で精製することができる。After completion of the reaction, the desired 2-aryl-5-halogenopyridine derivative represented by the general formula (3) can be isolated from the reaction mixture by a usual separation means such as extraction, washing, and concentration. It can be purified by recrystallization, column chromatography and the like.
本発明の方法で製造された2−アリール−5−ハロゲノ
ピリジン誘導体は、種々の液晶化合物の中間体として有
用であり、かつ医薬、農薬等の中間体としても利用する
ことができる。The 2-aryl-5-halogenopyridine derivative produced by the method of the present invention is useful as an intermediate for various liquid crystal compounds, and can also be used as an intermediate for medicines, agricultural chemicals and the like.
例えば本発明の方法で製造された2−アリール−5−ハ
ロゲノピリジン誘導体を中間体として、下記のような液
晶化合物を得ることができる。For example, the following liquid crystal compound can be obtained by using the 2-aryl-5-halogenopyridine derivative produced by the method of the present invention as an intermediate.
上記化合物のうち、化合物(12)、(13)および(14)
は文献記載の化合物であり、これまではβ−クロロビニ
ルケトンとエナミンより得る方法〔例えば特開昭62-223
171号公報〕フェニル酢酸誘導体とケトン体より得る方
法〔例えば特開昭63-250365号公報〕、アリールリチウ
ム誘導体とピリジンおよびアルキルブロマイドとの反応
により得る方法〔例えば特開昭63-174973号公報〕によ
り合成されてきた。これに対し本発明の方法により得ら
れる化合物を中間体として用いることにより、短い合成
ルートで、簡単かつ高収率に得ることが可能となった。 Of the above compounds, compounds (12), (13) and (14)
Is a compound described in the literature, and hitherto a method obtained from β-chlorovinyl ketone and an enamine [eg, JP-A-62-223
171] Method obtained from phenylacetic acid derivative and ketone body [eg JP-A-63-250365], Method obtained by reaction of aryl lithium derivative with pyridine and alkyl bromide [eg JP-A-63-174973] Has been synthesized by. On the other hand, by using the compound obtained by the method of the present invention as an intermediate, it became possible to obtain it easily and in high yield by a short synthetic route.
また化合物(11)は、上記従来の方法では合成すること
のできなかった化合物であり、本発明の方法により得ら
れる化合物を中間体として用いることにより初めて合成
が可能となった。Further, the compound (11) was a compound that could not be synthesized by the above-mentioned conventional method, and it was possible to synthesize the compound (11) only by using the compound obtained by the method of the present invention as an intermediate.
化合物(11)〜(14)の液晶としての有用性の指標とし
てこれらの化合物の相転移温度を表−3に示す。Table 3 shows the phase transition temperatures of the compounds (11) to (14) as indices of usefulness as liquid crystals.
表−3中、各記号はそれぞれ以下の相を表す。 In Table 3, each symbol represents the following phase.
Cr;結晶相 S1;未同定スメクチック相 SC;スメクチックC相 SA;スメクチックA相 N ;ネマチック相 I ;等方性液体相 [実施例] 以下、本発明を実施例により更に説明するが、本発明は
これに限定されない。Cr; Crystal phase S 1 ; Unidentified smectic phase S C ; Smectic C phase S A ; Smectic A phase N; Nematic phase I; Isotropic liquid phase [Examples] Hereinafter, the present invention will be further described with reference to Examples. However, the present invention is not limited to this.
実施例−1 下記化合物(15)の製造 o−フルオロ−p−ヨードフェノール30.0gをジメ
チルスルホキシド150mlに溶かし、これに水酸化ナトリ
ウム水溶液(10.1g/35ml)および1−ブロモヘキサン2
5.0gを加え、室温で4日間攪拌した。反応混合物をヘキ
サンで抽出、3回水洗した。ヘキサンを留去することに
より、油状のp−n−ヘキシルオキシ−m−フルオロヨ
ードベンゼン34.6gを得た。Example-1 Production of Compound (15) 30.0 g of o-fluoro-p-iodophenol was dissolved in 150 ml of dimethyl sulfoxide, and an aqueous solution of sodium hydroxide (10.1 g / 35 ml) and 1-bromohexane 2 were added.
5.0 g was added, and the mixture was stirred at room temperature for 4 days. The reaction mixture was extracted with hexane and washed 3 times with water. Hexane was distilled off to obtain 34.6 g of oily pn-hexyloxy-m-fluoroiodobenzene.
p−n−ヘキシルオキシ−m−フルオロヨードベン
ゼン15.0gとマグネシウムより調整したグリニャール試
薬のエーテル溶液120mlと、2,5−ジブロモピリジン13.2
gの乾燥テトラヒドロフラン溶液120mlとを、触媒にジク
ロロビスジフェニルホスフィノブタンパラジウム338mg
を用いて、窒素雰囲気下室温で5時間反応させた。水で
反応を止め、反応混合物をエーテルで抽出、1N塩酸、水
で順次洗浄後、エーテルを留去した。得られた固体をメ
タノールから再結晶することにより、本発明の化合物で
ある化合物(15)10.0gを得た。化合物の構造は、NMR
(核磁気共鳴スペクトル分析)、MS(質量分析)、IR
(赤外吸収スペクトル分析)および元素分析により確認
した。上記化合物のIRスペクトル、H-NMRスペクトルお
よびF-NMRスペクトルをそれぞれ第1図、第2図および
第3図に示す。pn-hexyloxy-m-fluoroiodobenzene 15.0 g and 120 ml ether solution of Grignard reagent prepared from magnesium, and 2,5-dibromopyridine 13.2
120 ml of a dry tetrahydrofuran solution of g and 338 mg of dichlorobisdiphenylphosphinobutane palladium as a catalyst.
Was used for 5 hours at room temperature in a nitrogen atmosphere. The reaction was stopped with water, the reaction mixture was extracted with ether, washed successively with 1N hydrochloric acid and water, and then the ether was distilled off. By recrystallizing the obtained solid from methanol, 10.0 g of the compound (15) of the present invention was obtained. The structure of the compound is NMR
(Nuclear magnetic resonance spectrum analysis), MS (mass spectrometry), IR
(Infrared absorption spectrum analysis) and elemental analysis confirmed. The IR spectrum, H-NMR spectrum and F-NMR spectrum of the above compound are shown in FIG. 1, FIG. 2 and FIG. 3, respectively.
元素分析値:理論値(%) 実測値(%) C:57.97 C:57.88 H: 5.44 H: 5.49 F: 5.39 F: 5.33 N: 3.98 N: 4.03 実施例−2 下記化合物(16)の製造 o−フルオロ−p−ヨードフェノール30.0gをジメ
チルスルホキシド150mlに溶かし、これに水酸化ナトリ
ウム水溶液(10.1g/35ml)および1−ブロモヘプタン2
7.2gを加え、室温で4日間攪拌した。反応混合物をヘキ
サンで抽出、3回水洗した。ヘキサンを留去することに
より、油状のp−n−ヘプチルオキシ−m−フルオロヨ
ードベンゼン36.5gを得た。Elemental analysis value: Theoretical value (%) Actual value (%) C: 57.97 C: 57.88 H: 5.44 H: 5.49 F: 5.39 F: 5.33 N: 3.98 N: 4.03 Example-2 Preparation of the following compound (16) 30.0 g of o-fluoro-p-iodophenol was dissolved in 150 ml of dimethyl sulfoxide, and an aqueous solution of sodium hydroxide (10.1 g / 35 ml) and 1-bromoheptane 2 were added to the solution.
7.2 g was added, and the mixture was stirred at room temperature for 4 days. The reaction mixture was extracted with hexane and washed 3 times with water. Hexane was distilled off to obtain 36.5 g of oily pn-heptyloxy-m-fluoroiodobenzene.
p−n−ヘプチルオキシ−m−フルオロヨードベン
ゼン15.7gとマグネシウムより調整したグリニャール試
薬のエーテル溶液120mlと、2,5−ジブロモピリジン13.2
gの乾燥テトラヒドロフラン溶液120mlとを、触媒にジク
ロロビスジフェニルホスフィノブタンパラジウム338mg
を用いて、窒素雰囲気下室温で5時間反応させた。水で
反応を止め、反応混合物をエーテルで抽出、1N塩酸、水
で順次洗浄後、エーテルを留去した。得られた固体をメ
タノールから再結晶することにより、本発明の化合物で
ある化合物(16)10.5gを得た。化合物(16)の元素分
析値を下記に示す。p-n-heptyloxy-m-fluoroiodobenzene (15.7 g) and magnesium solution of 120 ml of Grignard reagent prepared from magnesium, and 2,5-dibromopyridine (13.2 g).
120 ml of a dry tetrahydrofuran solution of g and 338 mg of dichlorobisdiphenylphosphinobutane palladium as a catalyst.
Was used for 5 hours at room temperature in a nitrogen atmosphere. The reaction was stopped with water, the reaction mixture was extracted with ether, washed successively with 1N hydrochloric acid and water, and then the ether was distilled off. By recrystallizing the obtained solid from methanol, 10.5 g of compound (16), which is the compound of the present invention, was obtained. The elemental analysis values of the compound (16) are shown below.
元素分析値:理論値(%) 実測値(%) C:59.03 C:58.91 H: 5.78 H: 5.77 F: 5.19 F: 5.22 N: 3.82 N: 3.80 実施例−3 下記化合物(17)の製造 o−フルオロ−p−ヨードフェノール30.0gをジメ
チルスルホキシド150mlに溶かし、これに水酸化ナトリ
ウム水溶液(10.1g/35ml)および1−ブロモオクタン2
9.2gを加え、室温で4日間攪拌した。反応混合物をヘキ
サンで抽出、3回水洗した。ヘキサンを留去することに
より、油状のp−n−オクチルオキシ−m−フルオロヨ
ードベンゼン37.6gを得た。Elemental analysis value: Theoretical value (%) Actual value (%) C: 59.03 C: 58.91 H: 5.78 H: 5.77 F: 5.19 F: 5.22 N: 3.82 N: 3.80 Example-3 Production of the following compound (17) 30.0 g of o-fluoro-p-iodophenol was dissolved in 150 ml of dimethyl sulfoxide, and an aqueous solution of sodium hydroxide (10.1 g / 35 ml) and 1-bromooctane 2 were dissolved in this solution.
9.2 g was added, and the mixture was stirred at room temperature for 4 days. The reaction mixture was extracted with hexane and washed 3 times with water. Hexane was distilled off to obtain 37.6 g of oily pn-octyloxy-m-fluoroiodobenzene.
p−n−オクチルオキシ−m−フルオロヨードベン
ゼン16.3gとマグネシウムより調整したグリニャール試
薬のエーテル溶液120mlと、2,5−ジブロモピリジン13.2
gの乾燥テトラヒドロフラン溶液120mlとを、触媒にジク
ロロビスジフェニルホスフィノブタンパラジウム338mg
を用いて、窒素雰囲気下室温で5時間反応させた。水で
反応を止め、反応混合物をエーテルで抽出、1N塩酸、水
で順次洗浄合物をエーテルで抽出、IN塩酸、水で順次洗
浄後、エーテルを留去した。得られた固体をメタノール
から再結晶することにより、本発明の化合物である化合
物(17)10.2gを得た。化合物(17)の元素分析値を下
記に示す。p-n-octyloxy-m-fluoroiodobenzene 16.3 g and 120 ml ether solution of Grignard reagent prepared from magnesium, and 2,5-dibromopyridine 13.2
120 ml of a dry tetrahydrofuran solution of g and 338 mg of dichlorobisdiphenylphosphinobutane palladium as a catalyst.
Was used for 5 hours at room temperature in a nitrogen atmosphere. The reaction was stopped with water, the reaction mixture was extracted with ether, washed successively with 1N hydrochloric acid and water, and the combined product was extracted with ether, washed successively with IN hydrochloric acid and water, and then the ether was distilled off. The obtained solid was recrystallized from methanol to obtain 10.2 g of the compound (17) of the present invention. The elemental analysis values of the compound (17) are shown below.
元素分析値:理論値(%) 実測値(%) C:60.01 C:59.92 H: 6.10 H: 6.15 F: 5.00 F: 5.02 N: 3.68 N: 3.66 実施例−4 下記化合物(18)の製造 p−ヨードフェノール25.0gをジメチルスルホキシ
ド200mlに溶かし、これに水酸化ナトリウム水溶液(9.0
g/30ml)および1−ブロモヘキサン17.8gを加え、室温
で4日間攪拌した。反応混合物をヘキサンで抽出、3回
水洗した。ヘキサンを留去することにより、油状のp−
n−ヘキシルオキシ−ヨードベンゼン31.0gを得た。Elemental analysis value: Theoretical value (%) Actual value (%) C: 60.01 C: 59.92 H: 6.10 H: 6.15 F: 5.00 F: 5.02 N: 3.68 N: 3.66 Example-4 Production of following compound (18) 25.0 g of p-iodophenol was dissolved in 200 ml of dimethyl sulfoxide, and an aqueous solution of sodium hydroxide (9.0
g / 30 ml) and 17.8 g of 1-bromohexane were added, and the mixture was stirred at room temperature for 4 days. The reaction mixture was extracted with hexane and washed 3 times with water. By distilling off hexane, an oily p-
31.0 g of n-hexyloxy-iodobenzene was obtained.
p−n−ヘキシルオキシ−ヨードベンゼン15.0gと
マグネシウムより調整したグリニャール試薬のエーテル
溶液120mlと、2,5−ジブロモピリジン14.0gの乾燥テト
ラヒドロフラン溶液120mlとを、触媒にジクロロビスジ
フェニルホスフィノブタンパラジウム357mgを用いて、
窒素雰囲気下室温で5時間反応させた。水で反応を止
め、反応混合物をエーテルで抽出、1N塩酸、水で順次洗
浄後、エーテルを留去した。得られた固体をメタノール
から再結晶することにより、本発明の化合物である化合
物(18)8.9gを得た。化合物の構造は、NMR(核磁気共
鳴スペクトル分析)、MS(質量分析)、IR(赤外吸収ス
ペクトル分析)および元素分析により確認した。上記化
合物のIRスペクトルおよびH-NMRスペクトルをそれぞれ
第4図および第5図に示す。p-n-Hexyloxy-iodobenzene 15.0 g and an ether solution of Grignard reagent prepared from magnesium 120 ml, and a solution of 2,5-dibromopyridine 14.0 g in dry tetrahydrofuran 120 ml were used as catalysts and dichlorobisdiphenylphosphinobutane palladium 357 mg. Using,
The reaction was carried out at room temperature under a nitrogen atmosphere for 5 hours. The reaction was stopped with water, the reaction mixture was extracted with ether, washed successively with 1N hydrochloric acid and water, and then the ether was distilled off. The obtained solid was recrystallized from methanol to obtain 8.9 g of the compound (18) of the present invention. The structure of the compound was confirmed by NMR (nuclear magnetic resonance spectrum analysis), MS (mass spectrometry), IR (infrared absorption spectrum analysis) and elemental analysis. The IR spectrum and 1 H-NMR spectrum of the above compound are shown in FIGS. 4 and 5, respectively.
元素分析値:理論値(%) 実測値(%) C:61.09 C:61.00 H: 6.03 H: 6.08 N: 4.19 N: 4.20 [発明の効果] 本発明の方法によれば、短い合成ルートで高収率に2−
アリール−5−ハロゲノピリジン誘導体を得ることがで
きる。こうして製造されたピリジン誘導体は種々の液晶
化合物の中間体として有用であり、かつ医薬、農薬等の
中間体としても利用することができる。Elemental analysis value: Theoretical value (%) Actual measurement value (%) C: 61.09 C: 61.00 H: 6.03 H: 6.08 N: 4.19 N: 4.20 [Effect of the invention] According to the method of the present invention, a high synthetic route 2-in yield
An aryl-5-halogenopyridine derivative can be obtained. The pyridine derivative thus produced is useful as an intermediate for various liquid crystal compounds, and can also be used as an intermediate for medicines, agricultural chemicals and the like.
第1図、第2図および第3図はそれぞれ実施例−1で得
られた化合物のIR、H-NMRおよびF-NMRスペクトルを、第
4図および第5図はそれぞれ実施例−4で得られた化合
物のIRおよびH-NMRスペクトルを示す。1, 2 and 3 show the IR, H-NMR and F-NMR spectra of the compound obtained in Example-1, respectively, and FIGS. 4 and 5 show it in Example-4. The IR and 1 H-NMR spectra of the obtained compound are shown.
Claims (1)
ノピリジンと一般式 R-Y-A-Mg-X1 (2) 〔式中、Rは炭素数1〜18のアルキル基(該アルキル基
は、1個または2個のCH2がO原子、S原子および−CH
=CH−からなる群より選ばれるものにより、2個のO原
子またはS原子が相互に直接に結合していないものとし
て置き換えられていてもよい)、X1は塩素原子、臭素原
子またはヨウ素原子、Aは芳香環の水素原子の一部また
は全部がフッ素原子または塩素原子で置換されていても
よい1,4−フェニレン基または4,4′−ビフェニレン基、
Yは−O−、−S−、−C≡C−または直接結合を表
す〕で示される化合物とを、0価または2価のパラジウ
ム触媒もしくは0価または2価のニッケル触媒存在下に
クロスカップリングさせることを特徴とする一般式 〔式中、Rは炭素数1〜18のアルキル基(該アルキル基
は、1個または2個のCH2がO原子、S原子および−CH
=CH−からなる群より選ばれるものにより、2個のO原
子またはS原子が相互に直接に結合していないものとし
て置き換えられていてもよい)、 は2,5−ピリジレン基、Xは塩素原子、臭素原子または
ヨウ素原子、Aは芳香環の水素原子の一部または全部が
フッ素原子または塩素原子で置換されていてもよい1,4
−フェニレン基または4,4′−ビフェニレン基、Yは−
O−、−S−、−C≡C−または直接結合を表す〕で示
される2−アリール−5−ハロゲノピリジン誘導体の製
造法。1. A general formula [In the formula, X represents a chlorine atom, a bromine atom or an iodine atom, Represents a 2,5-pyridylene group] and a general formula RYA-Mg-X 1 (2) [wherein, R represents an alkyl group having 1 to 18 carbon atoms (the alkyl group). 1 or 2 CH 2 is an O atom, an S atom or -CH
2 O atoms or S atoms may be replaced by those not directly bonded to each other by a group selected from the group consisting of = CH-), X 1 is a chlorine atom, a bromine atom or an iodine atom. , A is a 1,4-phenylene group or 4,4′-biphenylene group in which some or all of the hydrogen atoms of the aromatic ring may be substituted with fluorine atoms or chlorine atoms,
Y represents -O-, -S-, -C≡C- or a direct bond] with a compound represented by a formula (I) in the presence of a zero-valent or divalent palladium catalyst or a zero-valent or divalent nickel catalyst. General formula characterized by ringing [In the formula, R is an alkyl group having 1 to 18 carbon atoms (in the alkyl group, 1 or 2 CH 2 is an O atom, an S atom, and -CH
Two O atoms or S atoms may be replaced by those not directly bonded to each other by one selected from the group consisting of = CH-), Is a 2,5-pyridylene group, X is a chlorine atom, a bromine atom or an iodine atom, and A is a hydrogen atom of an aromatic ring, part or all of which may be substituted with a fluorine atom or a chlorine atom.
-Phenylene group or 4,4'-biphenylene group, Y is-
O-, -S-, -C≡C- or represents a direct bond].
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2052521A JPH0720937B2 (en) | 1990-03-02 | 1990-03-02 | Process for producing 2-aryl-5-halogenopyridine derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2052521A JPH0720937B2 (en) | 1990-03-02 | 1990-03-02 | Process for producing 2-aryl-5-halogenopyridine derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03255075A JPH03255075A (en) | 1991-11-13 |
| JPH0720937B2 true JPH0720937B2 (en) | 1995-03-08 |
Family
ID=12917049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2052521A Expired - Lifetime JPH0720937B2 (en) | 1990-03-02 | 1990-03-02 | Process for producing 2-aryl-5-halogenopyridine derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0720937B2 (en) |
-
1990
- 1990-03-02 JP JP2052521A patent/JPH0720937B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03255075A (en) | 1991-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109879733B (en) | Synthetic method of monofluoro bromoacetone derivative | |
| JP3586288B2 (en) | Preparation of biphenyl derivatives | |
| JPH0720937B2 (en) | Process for producing 2-aryl-5-halogenopyridine derivative | |
| JPH0543709B2 (en) | ||
| JP3477631B2 (en) | Purification method of 1,3-bis (3-aminopropyl) -1,1,3,3-tetraorganodisiloxane | |
| JPH0720936B2 (en) | 2-aryl-5-halogenopyridine derivatives | |
| JPS5838261A (en) | Novel 1,3-disubstituted imidazole derivative and its preparation | |
| JP2522926B2 (en) | Method for producing 2'-deoxy-5-trifluoromethyluridine derivative | |
| JP2705754B2 (en) | Method for producing .BETA.-ketothioamide derivatives | |
| JP2706554B2 (en) | 4-trifluoromethylaniline derivative and method for producing the same | |
| USH181H (en) | Bis(2-fluoro-2,2-dinitroethoxy)acetonitrile and a method of preparation | |
| JP2779539B2 (en) | Method for producing iodinated biphenyl derivative | |
| US6096894A (en) | Production method of 2-(p-alkylphenyl)pyridine compound | |
| JP2855831B2 (en) | New metal complex liquid crystal | |
| JPS59110644A (en) | Manufacture of cyclopentenone and novel acetylene ester | |
| HU193454B (en) | Process for producing 3-phenyl-butyraldehyde derivatives | |
| JPH03261768A (en) | Production of 3-aryl-6-halogenopyridazine derivative | |
| JPH0421659B2 (en) | ||
| JPH02164871A (en) | Production of 5-fluorouracil derivative | |
| JPS6126902B2 (en) | ||
| JPH0649685B2 (en) | 1-benzylpyridinium salt derivative and method for producing the same | |
| JPH03271243A (en) | Production of biphenyl derivative | |
| JPH06306005A (en) | Ether compound and production thereof | |
| JPS6244548B2 (en) | ||
| JPH01106877A (en) | Manufacture of diphenyl ether |